Long-distance effects of insertional mutagenesis

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Singhal, Ruchi ^a   Deng, Xiaotao ^b   Chenchik, Alex A ^b   Kandel, Eugene S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Cellecta Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RETROVIRUS VECTOR; MESSENGER RNA;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYO; ENHANCER REGION; EXON; GENE FUNCTION; GENE INSERTION; GENE LOCUS; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INSERTIONAL MUTAGENESIS; INTRON; LONG TERMINAL REPEAT; MUTAGENESIS; PHENOTYPE; POLYADENYLATION; PROMOTER REGION; RETROVIRUS; SIGNAL TRANSDUCTION; VIRUS DNA CELL DNA INTERACTION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC ENGINEERING; GENETICS; METHODOLOGY;

MAMMALIA;

GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; INTRONS; MUTAGENESIS, INSERTIONAL; POLYADENYLATION; RETROVIRIDAE; RNA, MESSENGER; TERMINAL REPEAT SEQUENCES;

EID: 79251535287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015832     Document Type: Article

References (29)

1. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256.
2. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, et al. (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
3. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG (2004) RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32: D523-527.
4. Kandel ES, Lu T, Wan Y, Agarwal MK, Jackson MW, et al. (2005) Mutagenesis by reversible promoter insertion to study the activation of NF-kappaB. Proc Natl Acad Sci U S A 102: 6425-6430.
5. Kandel ES, Stark GR (2003) Forward genetics in mammalian cells. In: Sehgal PB, Levy DE, Hirano T, eds. Signal Transducers and Activators of Transcription (STATs): Activation and Biology. The Netherlands: Kluwer Academic Publishers.
6. Lu T, Jackson MW, Singhi AD, Kandel ES, Yang M, et al. (2009) Validationbased insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkB. Proceedings of the National Academy of Sciences 106: 16339-16344.
7. Dasgupta M, Agarwal MK, Varley P, Lu T, Stark GR, et al. (2008) Transposonbased mutagenesis identifies short RIP1 as an activator of NF-kB. Cell Cycle 7: 2249-2256.
8. Kichina JV (2008) Transposons find a small RIP in NFkappaB pathway. Cell Cycle 7: 2081-2082.
9. Swain A, Coffin JM (1993) Influence of sequences in the long terminal repeat and flanking cell DNA on polyadenylation of retroviral transcripts. J Virol 67: 6265-6269.
10. Dye MJ, Gromak N, Proudfoot NJ (2006) Exon tethering in transcription by RNA polymerase II. Mol Cell 21: 849-859.
11. Neugebauer KM (2006) Please hold-the next available exon will be right with you. Nat Struct Mol Biol 13: 385-386.
12. Shagin DA, Barsova EV, Yanushevich YG, Fradkov AF, Lukyanov KA, et al. (2004) GFP-like proteins as ubiquitous metazoan superfamily: evolution of functional features and structural complexity. Mol Biol Evol 21: 841-850.
13. Lengler J, Holzmuller H, Salmons B, Gunzburg WH, Renner M (2005) FMDV- 2A sequence and protein arrangement contribute to functionality of CYP2B1- reporter fusion protein. Anal Biochem 343: 116-124.
14. Freundlieb S, Schirra-Muller C, Bujard H (1999) A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1: 4-12.
15. Li X, Commane M, Burns C, Vithalani K, Cao Z, et al. (1999) Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptorassociated kinase. Mol Cell Biol 19: 4643-4652.
16. Li X, Commane M, Nie H, Hua X, Chatterjee-Kishore M, et al. (2000) Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci U S A 97: 10489-10493.
17. Sathe SS, Sizemore N, Li X, Vithalani K, Commane M, et al. (2004) Mutant human cells with constitutive activation of NF-kappaB. Proc Natl Acad Sci U S A 101: 192-197.
18. Kandel ES, Nudler E (2002) Template switching by RNA polymerase II in vivo. Evidence and implications from a retroviral system. Mol Cell 10: 1495-1502.
19. Swain A, Coffin JM (1992) Mechanism of transduction by retroviruses. Science 255: 841-845.
20. Dong B, Silverman RH, Kandel ES (2008) A natural human retrovirus efficiently complements vectors based on murine leukemia virus. PLoS ONE 3: e3144.
21. Sotelo J, Esposito D, Duhagon MA, Banfield K, Mehalko J, et al. (2010) Longrange enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci U S A 107: 3001-3005.
22. Wright JB, Brown SJ, Cole MD (2010) Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 30: 1411-1420.
23. Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, et al. (2008) Pvt1- encoded microRNAs in oncogenesis. Retrovirology 5: 4.
24. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, et al. (2003) LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1. Science 302: 415-419.
25. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, et al. (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. The Journal of Clinical Investigation 118: 3143-3150.
26. Zhang F, Thornhill SI, Howe SJ, Ulaganathan M, Schambach A, et al. (2007) Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 110: 1448-1457.
27. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
28. Morgenstern JP, Land H (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596.
29. Matz MV, Alieva NO, Chenchik A, Lukyanov S (2003) Amplification of cDNA ends using PCR suppression effect and step-out PCR. Methods Mol Biol 221: 41-49.